Legacy effect of foxo1 in pancreatic endocrine progenitors on adult β-cell mass and function

Diabetes

Volumn 64, Issue 8, 2015, Pages 2868-2879

  Talchai, Shivatra Chutima ^a,b   Accili, Domenico ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b KING MONGKUT'S UNIVERSITY OF TECHNOLOGY THONBURI   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 6; INSULIN; MESSENGER RNA; NEUROGENIN 3; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR MAFA; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SOX9; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DIABETES MELLITUS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; INSULIN SYNTHESIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; STEM CELL; STEM CELL EXPANSION; STEM CELL SELF-RENEWAL; ANIMAL; CELL SIZE; CYTOLOGY; GENETICS; METABOLISM; PANCREAS ISLET; TRANSGENIC MOUSE;

ANIMALS; CELL SIZE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE INTOLERANCE; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC;

EID: 84964697562     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1696     Document Type: Article

References (48)

1. Vaag AA, Grunnet LG, Arora GP, Brøns C. The thrifty phenotype hypothesis revisited. Diabetologia 2012;55:2085-2088.
2. International Diabetes Federation. Diabetes Atlas. Brussels, Belgium, International Diabetes Federation, 2007.
3. Gatford KL, Simmons RA. Prenatal programming of insulin secretion in intrauterine growth restriction. Clin Obstet Gynecol 2013;56:520-528.
4. Holder T, Giannini C, Santoro N, et al. A low disposition index in adolescent offspring of mothers with gestational diabetes: A risk marker for the development of impaired glucose tolerance in youth. Diabetologia 2014;57:2413-2420.
5. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004;117:421-426.
6. Kitamura T, Nakae J, Kitamura Y, et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 2002;110:1839-1847.
7. Kitamura T, Kitamura YI, Kobayashi M, et al. Regulation of pancreatic juxtaductal endocrine cell formation by FoxO1. Mol Cell Biol 2009;29:4417-4430.
8. Kim-Muller JY, Zhao S, Srivastava S, et al. Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. Cell Metab 2014;20:593-602.
9. Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic β cell dedifferentiation as a mechanism of diabeticβcell failure. Cell 2012;150:1223-1234.
10. Kobayashi M, Kikuchi O, Sasaki T, et al. FoxO1 as a double-edged sword in the pancreas: Analysis of pancreas- And b-cell-specific FoxO1 knockout mice. Am J Physiol Endocrinol Metab 2012;302:E603-E613.
11. Kaneto H, Miyatsuka T, Shiraiwa T, et al. Crucial role of PDX-1 in pancreas development, beta-cell differentiation, and induction of surrogate beta-cells. Curr Med Chem 2007;14:1745-1752.
12. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002;129:2447-2457.
13. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008;455:627-632.
14. Smelt MJ, Faas MM, de Haan BJ, de Vos P. Pancreatic beta-cell purification by altering FAD and NAD(P)H metabolism. Exp Diabetes Res 2008;2008:165360.
15. Talchai C, Xuan S, Kitamura T, DePinho RA, Accili D. Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat Genet 2012;44: 406-412, .
16. Xuan S, Kitamura T, Nakae J, et al. Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J Clin Invest 2002;110:1011-1019.
17. Kido Y, Burks DJ, Withers D, et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 2000;105: 199-205.
18. Matoba S, Hiramatsu R, Kanai-Azuma M, et al. Establishment of testisspecific SOX9 activation requires high-glucose metabolism in mouse sex differentiation. Dev Biol 2008;324:76-87.
19. Pierreux CE, Poll AV, Kemp CR, et al. The transcription factor hepatocyte nuclear factor-6 controls the development of pancreatic ducts in the mouse. Gastroenterology 2006;130:532-541.
20. Kitamura YI, Kitamura T, Kruse JP, et al. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab 2005;2:153-163.
21. Okamoto H, Hribal ML, Lin HV, Bennett WR, Ward A, Accili D. Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. J Clin Invest 2006;116:775-782.
22. Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4:437-450.
23. Schonhoff SE, Giel-Moloney M, Leiter AB. Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and nonendocrine cell types. Dev Biol 2004;270:443-454.
24. Magnuson MA, Osipovich AB. Pancreas-specific CRE driver lines and considerations for their prudent use. Cell Metab 2013;18:9-20.
25. Rieck S, Kaestner KH. Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab 2010;21:151-158.
26. Stanger BZ, Tanaka AJ, Melton DA. Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature 2007;445: 886-891.
27. Johansson KA, Dursun U, Jordan N, et al. Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev Cell 2007;12:457-465.
28. Schwitzgebel VM, Scheel DW, Conners JR, et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 2000; 127:3533-3542.
29. Xu X, D'Hoker J, Stangé G, et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008;132:197-207.
30. Huang HP, Liu M, El-Hodiri HM, Chu K, Jamrich M, Tsai MJ. Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin 3. Mol Cell Biol 2000;20:3292-3307.
31. Wang S, Jensen JN, Seymour PA, et al. Sustained Neurog3 expression in hormone-expressing islet cells is required for endocrine maturation and function. Proc Natl Acad Sci U S A 2009;106:9715-9720.
32. Lee CS, Perreault N, Brestelli JE, Kaestner KH. Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev 2002;16:1488-1497.
33. Fatrai S, Elghazi L, Balcazar N, et al. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 2006;55:318-325.
34. Kitamura T, Kitamura YI, Funahashi Y, et al. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest 2007;117:2477- 2485.
35. Pajvani UB, Shawber CJ, Samuel VT, et al. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med 2011; 17:961-967.
36. Murtaugh LC, Stanger BZ, Kwan KM, Melton DA. Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci U S A 2003;100: 14920-14925.
37. Seymour PA, Freude KK, Tran MN, et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci U S A 2007;104:1865-1870.
38. Marselli L, Thorne J, Dahiya S, et al. Gene expression profiles of beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. Plos One 2010;5:e11499.
39. Puri S, Akiyama H, Hebrok M. VHL-mediated disruption of Sox9 activity compromises b-cell identity and results in diabetes mellitus. Genes Dev 2013; 27:2563-2575.
40. Tweedie E, Artner I, Crawford L, et al. Maintenance of hepatic nuclear factor 6 in postnatal islets impairs terminal differentiation and function of beta-cells. Diabetes 2006;55:3264-3270.
41. Nef S, Verma-Kurvari S, Merenmies J, et al. Testis determination requires insulin receptor family function in mice. Nature 2003;426:291-295.
42. Elghazi L, Weiss AJ, Barker DJ, et al. Regulation of pancreas plasticity and malignant transformation by Akt signaling. Gastroenterology 2009;136:1091-1103.
43. Lynn FC, Smith SB, Wilson ME, Yang KY, Nekrep N, German MS. Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U S A 2007;104:10500-10505.
44. Al-Masri M, Krishnamurthy M, Li J, et al. Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas. Diabetologia 2010;53:699-711.
45. Murtaugh LC, Law AC, Dor Y, Melton DA. Beta-catenin is essential for pancreatic acinar but not islet development. Development 2005;132:4663-4674.
46. Heiser PW, Lau J, Taketo MM, Herrera PL, Hebrok M. Stabilization of βcatenin impacts pancreas growth. Development 2006;133:2023-2032.
47. Mondal P, Song WJ, Li Y, Yang KS, Hussain MA. Increasing β-cell mass requires additional stimulation for adaptation to secretory demand. Mol Endocrinol 2015;29:108-120.
48. Guo S, Dai C, Guo M, et al. Inactivation of specific βcell transcription factors in type 2 diabetes. J Clin Invest 2013;123:3305-3316.